PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion
Accelerates revenue and earnings growth by adding leading positions in autoimmune and allergy diagnostics and strengthens leadership in China and other emerging markets Significant opportunity to leverage technologies, strong market positions and synergistic commercial activities to deliver better solutions across an expanding customer base Highly compelling deployment of capital, significantly advancing PerkinElmer’s strategic priorities and... Read more